[go: up one dir, main page]

MX2013006094A - Metodo para inhibir patogenos usando composicion nutricional. - Google Patents

Metodo para inhibir patogenos usando composicion nutricional.

Info

Publication number
MX2013006094A
MX2013006094A MX2013006094A MX2013006094A MX2013006094A MX 2013006094 A MX2013006094 A MX 2013006094A MX 2013006094 A MX2013006094 A MX 2013006094A MX 2013006094 A MX2013006094 A MX 2013006094A MX 2013006094 A MX2013006094 A MX 2013006094A
Authority
MX
Mexico
Prior art keywords
nutritional composition
inhibiting
inhibiting pathogens
human
pathogens
Prior art date
Application number
MX2013006094A
Other languages
English (en)
Inventor
Robert J Mcmahon
Dattatreya Banavara
Anja Wittke
Cecilia Munoz
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,813 external-priority patent/US8648036B2/en
Priority claimed from US12/980,808 external-priority patent/US20120171163A1/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of MX2013006094A publication Critical patent/MX2013006094A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pediatric Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un método para inhibir un mecanismo invasivo bacteriano o de adhesión que involucra administrar a un ser humano una composición nutricional que incluye un lípido o grasa; una fuente de proteína; una composición de prebiótico; y por lo menos aproximadamente 10 mg/100kCal de lactoferrina producida por una fuente no humana.
MX2013006094A 2010-12-29 2011-12-15 Metodo para inhibir patogenos usando composicion nutricional. MX2013006094A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/980,813 US8648036B2 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
US12/980,808 US20120171163A1 (en) 2010-12-29 2010-12-29 Method for inhibiting a bacterial invasive mechanism using a nutritional composition
PCT/US2011/065231 WO2012091946A2 (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition

Publications (1)

Publication Number Publication Date
MX2013006094A true MX2013006094A (es) 2013-07-03

Family

ID=45496273

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013006094A MX2013006094A (es) 2010-12-29 2011-12-15 Metodo para inhibir patogenos usando composicion nutricional.

Country Status (13)

Country Link
EP (1) EP2658388A2 (es)
CN (1) CN103327828B (es)
BR (1) BR112013011642B1 (es)
CA (1) CA2822892C (es)
EC (1) ECSP13012798A (es)
MX (1) MX2013006094A (es)
MY (1) MY174494A (es)
PE (1) PE20141192A1 (es)
PH (1) PH12013500916A1 (es)
RU (1) RU2013128920A (es)
SG (2) SG10201508194RA (es)
TW (1) TWI626893B (es)
WO (1) WO2012091946A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
BR112015012105A2 (pt) * 2012-12-18 2017-07-11 Mjn Us Holdings Llc composições nutricionais baseadas em leite contendo lactoferrina e usos das mesmas
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
EP3681511B1 (en) * 2017-09-10 2025-10-29 Technion Research & Development Foundation Limited Composition and method for a prebiotic delivery system targeted to probiotic bacteria
GB2618609A (en) * 2022-05-13 2023-11-15 Lintbells Ltd Methods and processes for manufacture of a topically adherent selective bactericide
WO2024056786A1 (en) 2022-09-14 2024-03-21 N.V. Nutricia Nutritional composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ATE200619T1 (de) 1991-01-24 2001-05-15 Martek Corp Mikrobielle öle und ihre verwendungen
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
EP1142484A2 (en) 1994-02-16 2001-10-10 Pharming Intellectual Property BV Isolation of lactoferrin from milk
EP1480524B1 (en) 2002-03-07 2013-04-17 Upfront Chromatography A/S A process of isolating lactoferrin
US20070191264A1 (en) * 2005-05-05 2007-08-16 Bristol-Myers Squibb Company, A Delaware Corporation Methods for inhibiting the growth of bacteria
CN101247823A (zh) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 牛乳铁蛋白在制备抑制细菌生长的药物中的用途
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
MX348901B (es) * 2007-11-26 2017-07-03 Nestec Sa Sistema nutricional adaptado a la edad para infantes.
ITRM20080163A1 (it) * 2008-03-26 2009-09-27 Maurizio Acri Uso della lattoferrina per la prevenzione delle sepsi neonatali in neonati prematuri
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
CN102724886A (zh) * 2009-10-29 2012-10-10 雀巢产品技术援助有限公司 包含乳铁蛋白和益生菌的营养组合物及其套盒

Also Published As

Publication number Publication date
BR112013011642A2 (pt) 2016-07-12
BR112013011642B1 (pt) 2020-04-07
HK1189456A1 (zh) 2014-06-13
WO2012091946A3 (en) 2012-09-07
CA2822892A1 (en) 2012-07-05
TWI626893B (zh) 2018-06-21
CN103327828A (zh) 2013-09-25
MY174494A (en) 2020-04-23
CN103327828B (zh) 2016-05-11
SG190781A1 (en) 2013-07-31
TW201238503A (en) 2012-10-01
CA2822892C (en) 2020-04-28
PH12013500916A1 (en) 2024-06-03
EP2658388A2 (en) 2013-11-06
ECSP13012798A (es) 2013-09-30
PE20141192A1 (es) 2014-10-01
SG10201508194RA (en) 2015-11-27
RU2013128920A (ru) 2015-02-10
WO2012091946A2 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
MX2013006094A (es) Metodo para inhibir patogenos usando composicion nutricional.
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
BR112014009418A2 (pt) macrociclos peptidomiméticos
IN2014DN03449A (es)
MX350325B (es) Bacteria para usarse como un probiotico para aplicaciones nutricionales y medicas.
CL2013002210A1 (es) Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano.
PH12013501892A1 (en) Nutritional compositions including branched chain fatty acids for wound healing
MX2021000715A (es) Composiciones y metodos para tratar trastornos metabolicos.
IN2014CN03749A (es)
MX342733B (es) Composicion nutricional para promover el desarrollo y crecimiento sano.
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
MY158504A (en) Fatty acid niacin conjugates and their uses
TR201904719T4 (tr) Diyet proteinlerine karşı toleransın oral indüksiyonu için sindirilemeyen oligosakkaridler.
BR112012017690A2 (pt) Emulsões nutricionais compreendendo hmb de cálcio
BR112014016251A8 (pt) composições e métodos para modificação da flora gastrointestinal
BR112013028709A2 (pt) cepas bacterianas capazes de metabolizar oxalatos
PH12014500558A1 (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
BR112014027820A2 (pt) controle dietário de doença celíaca e alergias alimentares
MX343326B (es) Metodos para mejorar el metabolismo energetico.
BR112013025974A2 (pt) produto de alimentação compreendendo camadas diferentes
PH12014500796A1 (en) Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
MY161933A (en) Fortified Milk-Based Nutritional Compositions
BR112013027474A2 (pt) composições que melhoram a palatabilidade
PH12013500917A1 (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
SG190952A1 (en) Compositions and methods for treating amyloid plaque associated symptoms